Venture Life Group (LON:VLG) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

Venture Life Group plc (LON:VLG)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 54.72 and traded as low as GBX 53.47. Venture Life Group shares last traded at GBX 55, with a volume of 210,123 shares trading hands.

Venture Life Group Stock Up 4.6%

The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. The stock has a market cap of £72.99 million, a price-to-earnings ratio of -75.00, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The business’s 50 day moving average is GBX 55.64 and its 200 day moving average is GBX 54.72.

Venture Life Group (LON:VLG) last announced its earnings results on Tuesday, September 30th. The company reported GBX 0.83 earnings per share (EPS) for the quarter. Venture Life Group had a net margin of 1.44% and a return on equity of 0.99%. Equities analysts expect that Venture Life Group plc will post 6.1391542 earnings per share for the current year.

Insider Transactions at Venture Life Group

In other Venture Life Group news, insider Mark Adams acquired 88,999 shares of the firm’s stock in a transaction on Friday, October 3rd. The stock was purchased at an average cost of GBX 56 per share, for a total transaction of £49,839.44. Corporate insiders own 6.84% of the company’s stock.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.